Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-023809
Filing Date
2024-09-20
Accepted
2024-09-20 19:26:16
Documents
1
Period of Report
2024-09-19

Document Format Files

Seq Description Document Type Size
1 form4-09202024_110913.html 4  
1 form4-09202024_110913.xml 4 7664
  Complete submission text file 0001415889-24-023809.txt   9118
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Issuer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MORPHIMMUNE INC. 101 FOUNDRY DRIVE, SUITE 1200 WEST LAFAYETTE IN 47906
Business Address
Rosett Max (Reporting) CIK: 0001994071 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39580 | Film No.: 241314418